Introduction {#s1}
============

Auditory neuropathy spectrum disorder (ANSD) is a hearing disorder that can be diagnosed by an absent or abnormal auditory brainstem responses (ABR) and presence of outer hair cell function. The most prominent indication of the outer hair cell function is a clear cochlear microphonic in an ABR waveform with an absent or abnormal ABR response and the presence of otoacoustic emissions (OAEs)^[@r1]^.

The behavioral pure-tone thresholds (BPTT) of patients with ANSD vary greatly. In most cases, hearing thresholds fluctuate and are unstable. These symptoms often correlate with poor speech perception abilities, especially in the presence of background noise^[@r2]^. Sound localization abilities are also deteriorated^[@r3]^.

Disrupted neural synchrony despite normal peripheral activity can be caused by presynaptic dysfunction of the inner hair cells, this disrupted neural synchrony can occur in pre-, and postsynaptic nerve terminal synapses within the inner hair cells, and postsynaptic unmyelinated and myelinated dendrites, auditory ganglion cells and myelinated axons^[@r4]^. The typical etiologies of ANSD include prematurity, Cytomegalovirus (CMV), hyperbilirubinemia, anoxia, hypoxia, congenital brain anomalies, ototoxic drug exposure, and genetic factors^[@r5]^. Clinical evidence of ANSD can also be attributed to auditory nerve aplasia/dysplasia^[@r6],[@r7]^.

The rehabilitation options for ANSD patients depend on the individual's hearing needs and the location of the pathologies. Hearing aids may not be an effective treatment due to the auditory synchronization issues associated with the postsynaptic disorder^[@r8]^. Several studies have established that cochlear implant (CI) may be a good option for patients with ANSD^[@r8]-[@r10]^.

CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss) is a genetic syndrome that is classified as an ATP1A3 gene mutation-related neurological disorder. The prognosis for CAPOS syndrome is progressive. It generally starts with the sudden onset of cerebellar ataxia and febrile illness. Recurrent episodes have also been reported^[@r11]^. Hearing loss is a common symptom in patients with CAPOS syndrome, however the nature and prognosis of the disease can vary. In CAPOS syndrome, mutations in the ATP1A3 gene may cause auditory neuropathy that affect the postsynaptic site, resulting in a disruption in the synapses between the afferent auditory nerve and the inner hair cells^[@r12]^. This disruption is described as postsynaptic synaptopathy^[@r13]^. Auditory interventions can be confusing for subjects with ANSD, and an additional disorder, like CAPOS syndrome, furter complicates the course of interventions more markedly. Few studies on the benefits of CIs in subjects with ANSD and CAPOS syndrome have been reported in the literature. Therefore, this paper presents outcomes of CI in a rare case of ANSD with CAPOS syndrome.

Case Report {#s2}
===========

Our case was 14 years old during our study, and she suffered from varicella disease when she was 8 years old. Sudden hearing loss occurred after this febrile illness, and she received treatment procedure for idiopathic sudden hearing loss at a different hospital. The patient did not receive any audiological interventions until she visited our clinic. She was referred to our clinic when she was 11 years old with complaints of dizziness and vision problems, as well as hearing loss and poor speech understanding performance in the pre-sence of noise. Her audiometric evaluation when she was 11 years old (during her first visit) indicated moderate hearing loss with low-frequency sloping, as demonstrated by the audiogram in [Figure 1](#F1){ref-type="fig"}.

![Behavioral pure-tone air conduction thresholds at 11 years old.](MEDJ-34-318-f1){#F1}

Clear OAE responses were detected. ANSD was confirmed with an absent auditory brainstem response and presence of cochlear microphonics for both ears ([Figure 2](#F2){ref-type="fig"}). ABR was performed during natural sleep using the Interacoustics Eclipse (Interacoustics, Middlefart, Denmark) with ER-3A insert earphones. The stimulus artifact was confirmed by performing a control trace, after removing the insert earphones, and preventing the sound from being delivered to the ear. The patient's audiological evaluations at 11 years old (during her first visit) are summarized in [Table 1](#T1){ref-type="table"}.

![Click Evoked ABR result with rarefaction and condensation polarities for the patient. The upper part of the figure shows the cochlear microphonics which are indicated in the circle line. The lower part are the control traces (no stimulus presented to patient) for controlling any stimulus related artifact.](MEDJ-34-318-f2){#F2}

###### 

Audiological test results at 11 years old.

  Audiological Evaluations              Findings
  ------------------------------------- ------------------------------------------------------------
  Acoustic Immitance                    Normal tympanogram, acoustic reflexes absent for both ears
  Otoacoustic Emission (DPOAE)          Present for both ears
  Auditory Brainstem Response (ABR)     No response for both ears
  Cochlear Microphonics                 Present for both ears
  Audiogram configuration               Reverse sloping audiogram for both ears
  Unaided Speech Discrimination Score   34% for right ear, 38% for the left ear
  Aided Speech Discrimination Score     28%

The patient's prognosis deteriorated in speech understanding, balance, and vision. After genetic testing, she was diagnosed with CAPOS syndrome. Corresponding ATP1A3 analysis revealed that she carried a heterozygous variant, c.2491 G \> A: p.E831K of the ATP1A3 gene which is classified as 'pathogenic' by dbSNP and 'likely pathogenic' by the CLINVAR database (https://www.ncbi.nlm.nih.gov/clinvar/). This genetic variant was not detected in the patient's parents. Radiological evaluations confirmed that there were no cochlear and/or auditory nerve malformations.

The patient briefly used bilateral a hearing aid equipped with frequency modulation (FM) system, but she rejected the device after complaints of poor speech perception abilities. Our speech perception evaluations also confirmed that she did not benefit from the hearing aids ([Table 1](#T1){ref-type="table"}). After her one-year follow-up, when she was 12 years old, she received a unilateral CI (Cochlear Nucleus CI 24RE) in the right ear. All the electrode impedance telemetry values were within a normal ranges. Electrical compound action potentials were detected for all electrodes using Neural Response Telemetry. Her CI was adjusted to her behavioral threshold and comfort level. The patient was followed up regularly with free field pure-tone audiometry, and her behavioral pure tone thresholds were within the range of 20-40 dB HL ([Figure 3](#F3){ref-type="fig"}).

![Behavioral frequency modulated tones thresholds with CI after one-year CI usage.](MEDJ-34-318-f3){#F3}

The speech audiometry was conducted using a mono-syllabic, phonetically balanced word discrimination test 14 in a sound-trated, double-walled room (IAC Acoustics, Sound Seal, IL, USA). Words were presented through loudspeakers that was positioned at 0° azimuth and 0° elevation and that were located 1-m from the patient. She had clear speech during the tests. Her word discrimination score increased as the duration of CI usage increased ([Figure 4](#F4){ref-type="fig"}). Her speech understanding in noise performance was tested with the Turkish Matrix Sentence Test^[@r15]^ and 50% speech reception threshold was reached at 7.4 dB SNR after one-year of CI usage. Her test score was in the above to normal range for normal hearing^[@r15]^ but dropped to the normal range for CI recipients, according to Hocberg et al.^[@r16]^.

![Pre (Last visit prior to CI) and Post-Operative Word discrimination score.](MEDJ-34-318-f4){#F4}

The patient's music perception abilities were also evaluated using the Turkish version of the Clinical Assessment of Music Perception Test (T-CAMP)^[@r17]^ (for detailed information on the testing materials and procedure please see Kang et al.^[@r18]^). Testing was conducted in a free field with custom MATLAB (MathWorks Inc., Matick, MA, USA) programs on a computer connected to a Madsen Astera Audiometer (Otometrics, Natus Medical, Denmark) with a sound field presentation level of 65 dBA. All stimuli were presented through a JBL Control One loudspeaker (JBL, Harman International, USA) that was positioned at 0° azimuth and 0° elevation and located 1-m from the subject. The subject scored 2,41 semitones on a pitch direction discrimination subtest and scored 45.83% and 8.33% on timbre and melody recognition subtests, respectively.

Discussion {#s3}
==========

In this paper, we documented a case of ANSD with CAPOS syndrome and our results suggest that after careful selection these patients can also benefit from CI as much as patients with SNHL.

There are only a few studies in the literature that evaluated patients with CAPOS syndrome and their CI outcomes. Han et al.^[@r12]^ reported 3 cases confirmed with ATP1A3 mutations and two of them underwent CI. They monitored speech performance for 6 months and the speech perception test scores improved as the duration of CI usage increased. Tranebjærg et al.^[@r11]^ presented 18 patients with CAPOS syndrome who had hearing problems and they stated that 4 patients received CI and two of them gained significant benefit from CI. Patients who have gained significant benefit from CI were younger than patients who have not. Considering the beneficial effects of CI in ANSD patients with disorders of inner hair cells, and the presence of synapses or the myelinated dendrites of spiral ganglion cells^[@r19]^, we can say that it is not surprising to observe beneficial effects of CI in patients with ATP1A3 mutation -related ANSD. CI can bypass the site of lesion in these patients and present a clear and synchronized signal to the auditory nerve. Synchronization of the auditory nerve helps to improve speech perception as a result of improved temporal synchrony and spectral resolution. It is well known that temporal auditory processing is degraded in patients with ANSD^[@r20]^ and consistent stimulation of CI electrodes can deliver the temporal envelope in each electrode, therefore improves the temporal synchrony^[@r21]^. Although some studies have suggested that patients with ANSD did not perform poorly in frequency discrimination test like they did in temporal processing tests^[@r22]^, it is still crucial to present spectrally rich information to the auditory nerve for good speech perception.

Contribution of temporal and spectral information in music perception is similar to speech perception. Broader spectral resolution with temporal information is crucial for good music perception. Our findings on the music perception is unique in the literature for ANSD patients with CAPOS syndrome. In previous studies CI users performed differently. Mean PDD scores ranged between 2.95^[@r21]^ and 4.6^[@r23]^ semitones, melody recognition scores between 10.61^[@r23],[@r24]^ and 29.6^[@r23]^ and timbre recognition scores between 34.09^[@r23],[@r24]^ and 48.2^[@r23]^.

Our patient's score on the timbre recognition test (45.83%) was superior to that detected in a previous study (34.09%) with similar study group^[@r24]^, possibly as a result of residual hearing capacity in high frequencies. Reverse sloping audiometric configuration is very common in patients with CAPOS syndrome and ANSD as reported in previous studies^[@r11],[@r12],[@r25]^. Although the contribution of residual hearing in case of ANSD is controversial, we can speculate that some benefit can still be achievable. Studies on the music perception abilities of CI users showed that, while low frequency residual hearing is beneficial for pitch perception^[@r26]^, timbre perception needs broader frequency perception especially in high frequencies. Timbre recognition performance of our patient might be the manifestation of the contribution of residual hearing in high frequencies. Scores observed in PDD and melody recognition subtest scores were similar to the scores obtained by the patients with sensorineural hearing loss in previous studies in this age range^[@r24]^, which can be a result of a similar low frequency hearing capacity in our case and in patients with severe/profound SNHL. Therefore, contribution of residual hearing in patients with ANSD should be considered.

Another consideration in case of CAPOS syndrome is the effect of optic atrophy and the possible deteriorations in the visual domain. Early diagnosis of the hearing loss and interventions with hearing aids and/or CIs have vital importance and can be life-changing for these patients. Prevention of sensory deprivation, especially in younger age, can confer lifelong benefit for patients with CAPOS syndrome.

Conclusion {#s4}
==========

We presented a patient who had ANSD with CAPOS syndrome that successfully received and benefited from CI. Audiological management of ANSD with CAPOS syndrome could be complicated as a result of complex nature of both disorders. After careful audiological follow-ups and detailed evaluations, patients should be considered as candidates for the implantation of cochlear implant.
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